Loading organizations...

§ Venture Capital · IL, USA
Private equity, venture capital, growth equity for founder-led lower middle-market B2B tech, services, healthcare, industrial tech globally.
Baird Capital is a private equity and venture capital firm that invests in lower middle market B2B technology, healthcare, and industrial solutions companies, and is headquartered in Chicago, Illinois. Operating as the direct private investment arm of Robert W. Baird and Co., the firm has raised more than $4 billion in capital and invested in over 340 companies across the United States, Europe, and Asia. The organization generates returns through equity appreciation and management fees, recently closing its second Global Fund with $340 million in commitments in 2021 and its sixth Venture Capital fund with $218 million in 2024. The firm's active investment portfolio features several notable technology and healthcare startups, including ChurnZero, Hireology, and Upfront Healthcare. Baird Capital was officially founded in 1989 as the dedicated private investment division of its parent financial services company.
Key people at Baird Capital.
Baird Capital was founded in 1919 by Steve Booth (Founder, Chairman, President & CEO).
Key people at Baird Capital.
Baird Capital is a global investment firm specializing in venture capital, growth equity, and private equity investments primarily in B2B technology and services sectors. Their mission centers on partnering with founder- and entrepreneur-led companies to provide not only capital but also operational support and strategic guidance to accelerate growth. They focus on sectors where they have deep institutional knowledge, including pharma services, healthcare, software, and business services. Baird Capital plays a significant role in the startup ecosystem by leveraging its global resources, executive networks, and flexible capital solutions to help companies scale internationally and optimize operations[1][2][3][4].
Baird Capital is part of Baird, a financial services firm founded in 1919 in Milwaukee, Wisconsin. Over time, Baird Capital evolved into a distinct investment arm managing two complementary strategies: Global Private Equity and Venture Capital. The firm’s leadership includes experienced partners such as Jim Pavlik, Benedict Rocchio, and Mike Liang, who guide investments in early to late-stage companies. The firm has a long history of investing in over 300 companies, emphasizing founder collaboration and leveraging Baird’s global brand and relationships to support growth ambitions[2][4][5].
Baird Capital rides the trend of increasing demand for technology-enabled B2B services and outsourced pharma services, sectors underpinned by long-term macro drivers such as globalization and digital transformation. Their timing aligns with growing market needs for specialized capital and operational expertise to scale companies internationally. By focusing on founder-led businesses and leveraging global resources, Baird Capital influences the broader ecosystem by enabling innovation and growth in critical technology and healthcare verticals, helping startups transition into mature, global enterprises[1][3][4].
Looking ahead, Baird Capital is poised to continue expanding its influence by deepening investments in high-growth B2B tech and healthcare sectors, particularly those benefiting from digital transformation and globalization. Trends such as AI integration, healthcare outsourcing, and SaaS adoption will likely shape their portfolio strategy. Their founder-centric approach and global platform position them well to support companies through scaling challenges and international expansion, reinforcing their role as a key partner in the evolving tech and services landscape[1][3][4]. This ongoing commitment ties back to their mission of being a trusted, growth-oriented partner for entrepreneurial companies worldwide.
Baird Capital was founded in 1919 by Steve Booth (Founder, Chairman, President & CEO).
Baird Capital has more than 26 tracked investments across 24 companies. The latest tracked deal is $2.0M Series U in Pimly in September 2025.